App-Quantinova.ai

The Absence of Mitochondrial Fusion Protein Optic Atrophy (OPA) -1 Exacerbates Platelet Dysfunction

Jesse W Rowley - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A Novel Rabbit Model of Plaque Erosion With Spontaneous Atherothrombotic Occlusion

Tetsuya Matoba - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Angiotensin II

Platelet Specific Knockout of Mitochondrial Superoxide Dismutase (Sod2) Impairs Mitochondrial Function and Increases Convulxin-Stimulated Platelet Activation

Jesse W Rowley - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Superoxide dismutase

Impact of Sirolimus-Eluting Stent Fractures Without Early Cardiac Events on Long-Term Clinical Outcomes: A Multislice Computed Tomography Study

Masashi Kimura - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

sirolimus

Use of the Multilayer Flow Modulator Stent as an Endovascular Therapeutic Alternative in the Treatment of High-Risk Thoraco-Abdominal Aneurysm

Yves Louvard - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Damage Analysis of Crimping Pericardial Leaflets in TAVI

Elliott M Groves - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Bivalirudin Bridging to Oral Anticoagulation After Left Ventricular Assist Device Implantation

Jodie M. Fink - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Clinical Impact of Acute Coronary Syndrome Due to Coronary Thromboembolism With Atrial Fibrillation

Keigo Dote - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Survivors of Prosthetic Valve Thrombosis: Predictors of Long-Term Outcome and Role of Medical Treatment at Discharge

Jose Fernando Rodriguez Palomares - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents

Robert W Yeh - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

ZoMaxx

Angiographic Outcomes After Percutaneous Coronary Intervention for Definite Stent Thrombosis

Kazushige Kadota - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Very Early Endotherialization After Nobori Stent Implantation on its Low Frequency of In-Stent Thrombosis: Evidence From Super Acute Examination in a Porcine Model

Shu Takabatake - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

Stent Thrombosis and Major Bleeding With Bivalirudin versus Active Control in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Behnood Bikdeli - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Left Atrial Appendage Morphology and Thromboembolic Risk After Catheter Ablation for Atrial Fibrillation. Does Shape Really Matter?

Jelena Kornej - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Increased Risk of Major Bleeding Complications in Women During Vka Treatment for Acute Venous Thromboembolism

Nienke van Rein - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

The Effects of Dabigatran on Fibrin Network Structure and Lysis: A Simple Technique to Monitor Efficacy of Treatment?

Rhodri King - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Real-World Cost of All-Cause Hospitalizations Over a 12-Month Period After Acute Venous Thromboembolism

Stephen Johnston - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

High Death and Re-Intervention Rate in Neonatal Modified Blalock-Taussig Shunts With Concomitant Patent Dutus Artertiosus: Mechanistic Insights Into Competitive Flow and Pulmonary Overcirculation

Madhi Esmaily Moghadam - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Gender Differences of Echocardiographic Characteristics in Non-Valvular Atrial fibrillation

Su-A Kim - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Mortality Rates Among Patients With Venous Thromboembolism on Anticoagulant Therapy

Xue Song - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Filters

7277 Abstracts